Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Terminated2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT04249947Phase 1Terminated
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
Acinic Cell TumorAdenoid Cystic CarcinomaGenital Neoplasms, Male+14 more
StudydirectorStart date: 2020-02-28
NCT03288493Phase 1/2Terminated
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Multiple Myeloma
StudydirectorStart date: 2017-09-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Prostate CancerNeoplasmsProstatic Neoplasms+1 more
Similarity Score7%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Prostate CancerMetastatic Castration-resistant Prostate CancerCarcinoma, Adenoid Cystic
Similarity Score5%

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

Prostate CancerNeoplasmsProstatic Neoplasms
Similarity Score5%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerMetastatic Castration-resistant Prostate CancerProstatic Neoplasms
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

NeoplasmsProstate Cancer
Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Multiple MyelomaProstate Cancer
Similarity Score4%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerMultiple Myeloma
Similarity Score4%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

NeoplasmsProstatic Neoplasms
Similarity Score4%

ICD

Sanofi

Related
17 trials

Shared therapeutic areas:

NeoplasmsProstatic Neoplasms
Similarity Score4%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Prostate CancerCancer of Salivary Gland
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04249947Phase 1StudyDirector

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Acinic Cell TumorAdenoid Cystic CarcinomaGenital Neoplasms, Male+14 more
Terminated
NCT03288493Phase 1/2StudyDirector

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

Multiple Myeloma
Terminated

All 2 trials loaded